Contineum Therapeutics (CTNM) Interest Coverage Ratio (2023)

Contineum Therapeutics has reported Interest Coverage Ratio over the past 1 years, most recently at 335.66 for Q2 2023.

  • Quarterly results put Interest Coverage Ratio at 335.66 for Q2 2023, changed N/A from a year ago — trailing twelve months through Mar 2024 was 97.09 (changed N/A YoY), and the annual figure for FY2023 was 77.29, changed.
  • Interest Coverage Ratio for Q2 2023 was 335.66 at Contineum Therapeutics, up from 55.6 in the prior quarter.
  • Over the last five years, Interest Coverage Ratio for CTNM hit a ceiling of 335.66 in Q2 2023 and a floor of 55.6 in Q1 2023.